Blog
DGAP-News: Q2 2022: DWS Stays Resilient with Strong Financial Results in Turbulent Markets
DGAP-News: Q2 2022: DWS Stays Resilient with Strong Financial Results in Turbulent Markets
Metall Zug AG: Clearances granted for closing of the combination between Schleuniger and Komax
Metall Zug AG: Clearances granted for closing of the combination between Schleuniger and Komax
Profitable growth continues with record results
Profitable growth continues with record results
Competition authorities grant clearance for combination of Komax and Schleuniger
Competition authorities grant clearance for combination of Komax and Schleuniger
DGAP-Adhoc: QIAGEN N.V.: QIAGEN increases full-year 2022 outlook
DGAP-Adhoc: QIAGEN N.V.: QIAGEN increases full-year 2022 outlook
DGAP-Adhoc: MagForce AG: Application for the Opening of Insolvency Proceedings
DGAP-Adhoc: MagForce AG: Application for the Opening of Insolvency Proceedings
DGAP-News: TAG Immobilien AG announces successful completion of capital increase
DGAP-News: TAG Immobilien AG announces successful completion of capital increase
ENOGIA: First-half 2022 revenue
ENOGIA: First-half 2022 revenue
PhosAgro PJSC: Notice on coupon payment
PhosAgro PJSC: Notice on coupon payment
DGAP-News: Burcon to Present at the Canaccord Genuity 42nd Annual Growth Conference
DGAP-News: Burcon to Present at the Canaccord Genuity 42nd Annual Growth Conference
DGAP-Adhoc: adidas AG: Slower recovery in Greater China and potential slowdown in other markets reflected in adjusted adidas outlook for financial year 2022
DGAP-Adhoc: adidas AG: Slower recovery in Greater China and potential slowdown in other markets reflected in adjusted adidas outlook for financial year 2022
BILENDI: Strong growth in Q2 2022
BILENDI: Strong growth in Q2 2022
Affluent Medical reports excellent safety and performance interim result of its Optimize II pivotal clinical study with Kalios TM , adjustable mitral ring, in the treatment of mitral regurgitation.
Affluent Medical reports excellent safety and performance interim result of its Optimize II pivotal clinical study with Kalios TM , adjustable mitral ring, in the treatment of mitral regurgitation.
DGAP-Adhoc: Petro Welt Technologies AG: Joma considers squeeze-out of minority shareholders according to Section 1 (1) of the Austrian Squeeze-out Act
DGAP-Adhoc: Petro Welt Technologies AG: Joma considers squeeze-out of minority shareholders according to Section 1 (1) of the Austrian Squeeze-out Act
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Tullow Oil plc
Form 8.3 - The Vanguard Group, Inc.: Tullow Oil plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: FirstGroup plc
Form 8.3 - The Vanguard Group, Inc.: FirstGroup plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc
Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: Capricorn Energy plc
Form 8.3 - The Vanguard Group, Inc.: Capricorn Energy plc


